These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579 [TBL] [Abstract][Full Text] [Related]
6. Eosinophils in COPD-Current Concepts and Clinical Implications. Mycroft K; Krenke R; Górska K J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737 [TBL] [Abstract][Full Text] [Related]
8. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations. Gao J; Chen B; Wu S; Wu F BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672 [TBL] [Abstract][Full Text] [Related]
9. Blood eosinophil levels as a biomarker in COPD. Brusselle G; Pavord ID; Landis S; Pascoe S; Lettis S; Morjaria N; Barnes N; Hilton E Respir Med; 2018 May; 138():21-31. PubMed ID: 29724389 [TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD. Antus B; Paska C; Barta I Int J Chron Obstruct Pulmon Dis; 2020; 15():2025-2035. PubMed ID: 32921998 [TBL] [Abstract][Full Text] [Related]
11. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD. Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204 [TBL] [Abstract][Full Text] [Related]
12. [Eosinophilic chronic obstructive pulmonary disease: A review]. Anaev EK Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908 [TBL] [Abstract][Full Text] [Related]
13. Blood and sputum eosinophils in COPD; relationship with bacterial load. Kolsum U; Donaldson GC; Singh R; Barker BL; Gupta V; George L; Webb AJ; Thurston S; Brookes AJ; McHugh TD; Wedzicha JA; Brightling CE; Singh D Respir Res; 2017 May; 18(1):88. PubMed ID: 28482840 [TBL] [Abstract][Full Text] [Related]
15. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease. Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427 [TBL] [Abstract][Full Text] [Related]
16. Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease. Cukic V Med Arch; 2017 Oct; 71(5):347-350. PubMed ID: 29284904 [TBL] [Abstract][Full Text] [Related]
17. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD. Schleich F; Corhay JL; Louis R Eur Respir J; 2016 May; 47(5):1562-4. PubMed ID: 26846827 [No Abstract] [Full Text] [Related]
18. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality. Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000 [TBL] [Abstract][Full Text] [Related]
19. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions. Couillard S; Larivée P; Courteau J; Vanasse A Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201 [TBL] [Abstract][Full Text] [Related]
20. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink. Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]